Mark Gabriel Lebwohl MD
Dean for Clinical Therapeutics, Professor and Chairman Emeritus of Dermatology, Icahn School of Medicine at Mount Sinai
5 e 98 stNew York, NY 10029
Overview of Dr. Lebwohl
Dr. Mark Lebwohl is a dermatologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, Mount Sinai Beth Israel, Mount Sinai Hospital of Queens, New York Eye and Ear Infirmary of Mount Sinai, and Mount Sinai Beth Israel Brooklyn. He received his medical degree from Harvard Medical School and has been in practice 48 years. He is one of 51 doctors at Mount Sinai Beth Israel Brooklyn and one of 24 doctors at New York Eye and Ear Infirmary of Mount Sinai who specialize in Dermatology. He has more than 100 publications and over 500 citings.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Dermatology, 1981 - 1983- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1978 - 1981
Harvard Medical SchoolClass of 1978
Certifications & Licensure
NY State Medical License 1980 - 2027
American Board of Dermatology Dermatology
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Gold Medal American Academy of Dermatology, 2022
- Top MD Consumers Checkbook
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
Publications & Presentations
PubMed
- Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.April W Armstrong, Mark Lebwohl, Richard B Warren, Akimichi Morita, Carle Paul
American Journal of Clinical Dermatology. 2026-08-07 - Injection Site Pain Levels with Biologic Medications for Atopic Dermatitis and Psoriasis: A Real-Life Study.Kateryna Karpoff, William C Lau, Mark Lebwohl
Journal of the American Academy of Dermatology. 2026-08-06 - Response to "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibit...Harrison P Nguyen, Eingun James Song, Edward Ted Lain, Jeffrey M Sobell, Linda Stein-Gold
Journal of the American Academy of Dermatology. 2026-08-01
Authored Content
- How Dermatologists Can Address Obesity to Improve Psoriasis OutcomesMarch 2025
Press Mentions
https://skin.dermsquared.com/skin/article/view/3978/2883May 26th, 2026- For Moderate-to-Severe Psoriasis, Novel Oral Therapy Acts like a Biologic in Phase 3 TrialNovember 12th, 2025
- Novartis Rhapsido Gets USFDA Nod for Chronic Spontaneous UrticariaOctober 1st, 2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
